Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorraine Blaise

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
La Revue Du Praticien|March 15, 2019
Benign liver tumorsLorraine Blaise, Olivier Sutter, Marianne Ziol, et al.
Anaesthesia, Critical Care & Pain Medicine|December 17, 2018
T-cell lymphoma with secondary hemophagocytic lymphohistiocytosis as a rare cause of acute liver failure T-cell lymphoma as a cause of acute liver failureYasmina Chouik, Lorraine Blaise, Marina Hachouf, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 30, 2020
Prognostic value of desmoplastic stroma in intrahepatic cholangiocarcinomaNathalie Guedj, Lorraine Blaise, François Cauchy, et al.
Clinics and Research in Hepatology and Gastroenterology|November 16, 2024
Prolonged survival in women with hepatocellular carcinoma: A French observational studyCécilia Busso, Jean-Charles Nault, Richard Layese, et al.
Alimentary Pharmacology & Therapeutics|June 10, 2023
Baveno VI and VII criteria are not suitable for screening for large varices or clinically significant portal hypertension in patients with hepatocellular carcinomaManon Allaire, Bertille Campion, Alix Demory, et al.
JHEP Reports : Innovation in Hepatology|November 11, 2024
Heterogeneity in adverse events related to atezolizumab-bevacizumab for hepatocellular carcinoma reported in real-world studiesClaudia Campani, Dimitrios Pallas, Sabrina Sidali, et al.
Clinics and Research in Hepatology and Gastroenterology|September 4, 2023
Albumin infusion reduces ascite occurrence in Child-Pugh B patients treated by Atezolizumab-Bevacizumab for advanced HCCSayma Chaibi, Edouard Larrey, Jean Pierre Couty, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 28, 2024
Portal hypertension is associated with poorer outcome and clinical liver decompensation in patients with HCC treated with Atezolizumab-BevacizumabPhilippe Sultanik, Claudia Campani, Edouard Larrey, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 18, 2022
A history of variceal bleeding is associated with further bleeding under atezolizumab-bevacizumab in patients with HCCEdouard Larrey, Bertille Campion, Manon Evain, et al.
Journal of Hepatocellular Carcinoma|January 4, 2023
Sulfatase 2 Along with Syndecan 1 and Glypican 3 Serum Levels are Associated with a Prognostic Value in Patients with Alcoholic Cirrhosis-Related Advanced Hepatocellular CarcinomaNesrine Mouhoubi, Jessica Bamba-Funck, Angela Sutton, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
La Revue Du Praticien|March 15, 2019
Benign liver tumorsLorraine Blaise, Olivier Sutter, Marianne Ziol, et al.
Anaesthesia, Critical Care & Pain Medicine|December 17, 2018
T-cell lymphoma with secondary hemophagocytic lymphohistiocytosis as a rare cause of acute liver failure T-cell lymphoma as a cause of acute liver failureYasmina Chouik, Lorraine Blaise, Marina Hachouf, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 30, 2020
Prognostic value of desmoplastic stroma in intrahepatic cholangiocarcinomaNathalie Guedj, Lorraine Blaise, François Cauchy, et al.
Clinics and Research in Hepatology and Gastroenterology|November 16, 2024
Prolonged survival in women with hepatocellular carcinoma: A French observational studyCécilia Busso, Jean-Charles Nault, Richard Layese, et al.
Alimentary Pharmacology & Therapeutics|June 10, 2023
Baveno VI and VII criteria are not suitable for screening for large varices or clinically significant portal hypertension in patients with hepatocellular carcinomaManon Allaire, Bertille Campion, Alix Demory, et al.
JHEP Reports : Innovation in Hepatology|November 11, 2024
Heterogeneity in adverse events related to atezolizumab-bevacizumab for hepatocellular carcinoma reported in real-world studiesClaudia Campani, Dimitrios Pallas, Sabrina Sidali, et al.
Clinics and Research in Hepatology and Gastroenterology|September 4, 2023
Albumin infusion reduces ascite occurrence in Child-Pugh B patients treated by Atezolizumab-Bevacizumab for advanced HCCSayma Chaibi, Edouard Larrey, Jean Pierre Couty, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 28, 2024
Portal hypertension is associated with poorer outcome and clinical liver decompensation in patients with HCC treated with Atezolizumab-BevacizumabPhilippe Sultanik, Claudia Campani, Edouard Larrey, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 18, 2022
A history of variceal bleeding is associated with further bleeding under atezolizumab-bevacizumab in patients with HCCEdouard Larrey, Bertille Campion, Manon Evain, et al.
Journal of Hepatocellular Carcinoma|January 4, 2023
Sulfatase 2 Along with Syndecan 1 and Glypican 3 Serum Levels are Associated with a Prognostic Value in Patients with Alcoholic Cirrhosis-Related Advanced Hepatocellular CarcinomaNesrine Mouhoubi, Jessica Bamba-Funck, Angela Sutton, et al.
Pageof 4